Open Nav


  • Ira Deyhimy, SELFA, Inc.

Secure A-round financing

  • Date:Thursday, October 18
  • Time:9:00 AM - 9:15 AM
  • Room:Elizabethan C
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:SELFA is a digital health company intent on bringing laboratory-quality diagnostics for infectious diseases, cardiac, and cancers to the point of care (POC), and ultimately to the home. SELFA’s semiconductor-based biosensor technology is ideally suited to bring about this evolution. SELFA’s technology is broadly applicable and our beachhead application is a rapid diagnostic test for a full panel of respiratory infections (e.g. flu). No available POC products offer rapid and sensitive test for all common respiratory pathogens and accommodate large patient volumes.
  • Company
  • Company HQ City:Westlake Village
  • Company HQ Country:United States
  • Company HQ State:California                  
  • Year Founded:2013
  • Main Therapeutic Focus:Diagnostics
  • Lead Product in Development :CLIA-Waived point of care respiratory panel
  • Development Phase of Primary Product:Pre-Clinical
  • Additional Information/Comments:Multi-national is development partner/investor patents granted: US, China, Japan, others pending
  • Total Amount Raised to Date, In All Rounds:$3.1M
Ira Deyhimy